Disseminated histoplasmosis with colonic ulcers in a patient receiving infliximab.
Gupta
Neil
N
Division of Gastroenterology/Hepatology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Fox
Christopher M
CM
Grisolano
Scott W
SW
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D003108:Colonic Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003113:Colonoscopy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D016469:Fungemia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006660:Histoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D018570:Risk Assessment; D014456:Ulcer / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000666:Amphotericin B; D000069285:Infliximab